Therapeutics News

DENVER – Orasis Pharmaceutical President and COO Paul Smith told Healio here at Optometry’s Meeting that the company is proceeding from positive phase 2 study results to enrollment for a phase 3 protocol.

DENVER – CBD oil, which is legal in all 50 states, can provide relief for a range of ocular and systemic conditions, Robert Reed Jr., OD, said here at Optometry’s Meeting.

Visual outcomes after cataract surgery depend on accurate planning.

Early detection is critical for traumatic brain injury patients to have the best chance of a successful recovery.

Data presented at the virtual Association for Research in Vision and Ophthalmology meeting showed that subjects dosed with Xiidra experienced improvement in dry eye disease and symptoms over 12 months.

ORLANDO – Use of Eyenovia’s MicroLine resulted in a three-line or more improvement in distance corrected near visual acuity in a statistically significant proportion of study subjects, according to a company representative.

At this year’s Vision Expo East, Justin A. Schweitzer, OD, FAAO, provided an overview of upcoming drug-delivery systems for glaucoma and their potential to help patients with compliance.

ORLANDO — Augmentin is a good go-to antibiotic choice for ocular infections, according to Nate Lighthizer, OD, FAAO, during his presentation on oral treatments for anterior segment disease here at Vision Expo East.

Texas joins the growing number of states to pass legislation that will broaden the scope of practice for its optometrists.

Interim results from a phase 2 study showed that Okogen’s topical OKG-0301 provided a safe and effective dose-dependent antiviral response in patients with acute adenoviral conjunctivitis, according to a poster presented at ARVO.